Hastings David C Insider Trades

Insider Trading History

Track insider trading activity for Hastings David C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Financial Officer
Holding Value $5.22M 375,000 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.81M 375,000 shares
$12.82
$13.93
Scynexis
Scynexis SCYX
Director
Holding Value $112k 23,000 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17k 23,000 shares
$0.74
$4.88
Scynexis
Scynexis SCYX
Director
Holding Value $338k 69,183 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.9k 23,000 shares
$0.74
$4.88
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Financial Officer
Holding Value $1.59M 365,800 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 365,800 shares
$3.29
$4.35
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Financial Officer
Holding Value $695k 159,724 shares
Last Trade
Feb 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$72.8k 22,183 shares
$3.28
$4.35
Scynexis
Scynexis SCYX
Director
Holding Value $225k 46,183 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.2k 23,000 shares
$1.88
$4.88
Scynexis
Scynexis SCYX
Director
Holding Value $112k 23,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.2k 23,000 shares
$1.88
$4.88
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Financial Officer
Holding Value $791k 181,907 shares
Last Trade
Feb 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.2k 9,593 shares
$2.31
$4.35
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Financial Officer
Holding Value $1.96M 450,000 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 450,000 shares
$2.40
$4.35
Scynexis
Scynexis SCYX
Director
Holding Value $113k 23,183 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.4k 10,000 shares
$2.74
$4.88
Scynexis
Scynexis SCYX
Director
Holding Value $48.8k 10,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.4k 10,000 shares
$2.74
$4.88
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Financial Officer
Holding Value $1.37M 316,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$916k 316,000 shares
$2.90
$4.35
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Financial Officer
Holding Value $344k 79,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$229k 79,000 shares
$2.90
$4.35
Vascular Biogenics
Vascular Biogenics VBLT
Director
Holding Value $0 0 shares
Last Trade
Jan 01, 2023 Sale
No data
No data
$0.16
Scynexis
Scynexis SCYX
Director
Holding Value $48.8k 10,000 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.8k 10,000 shares
$1.78
$4.88
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Financial Officer
Holding Value $1.24M 285,000 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$801k 285,000 shares
$2.81
$4.35
Scynexis
Scynexis SCYX
Director
Holding Value $48.8k 10,000 shares
Last Trade
Jun 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75.1k 10,000 shares
$7.51
$4.88
Entasis Therapeutics Holdings
Entasis Therapeutics Holdings ETTX
Director
Holding Value $48.2k 22,000 shares
Last Trade
Apr 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.5k 22,000 shares
$2.16
$2.19
Arbutus Biopharma
Arbutus Biopharma ABUS
Chief Financial Officer
Holding Value $1.09M 250,000 shares
Last Trade
Feb 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 250,000 shares
$4.33
$4.35
Scynexis
Scynexis SCYX
Director
Holding Value $220k 45,000 shares
Last Trade
Jul 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$330k 45,000 shares
$7.33
$4.88

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up